User Name Password

back to homepage

Soho Resources (SOH.V) - new NI 43-101-compliant mineral resource raises valuation

Update by Objective Capital , May 20, 2008 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • An initial mineral resource
    Mine Development Associates has calculated an inferred resource of 6.4 million tonnes, using an unoxidised gold-equivalent cut-off of 2.0 grams per tonne. The resource averages 1.34 grams of gold and 31 grams of silver per tonne, with 0.24 percent copper, 0.78 percent lead and 1.43 percent zinc. This translates to 276,000 ounces of gold, 6.43 million ounces of silver, 33.5 million pounds of copper, 110.5 million pounds of lead and 201.1 million pounds of zinc. Although the tonnage is greater than hypothesised, the average grades are significantly lower, which results in a neutral impact on our valuation.

  • Continued drilling yields further encouragement
    Soho continues its aggressive drill programme and assays from several zones continue to yield encouraging assays over significant widths. This supports our hypothesis that additional tonnage will be available at Tahuehueto.

  • Higher precious metal prices
    The price of gold surged to an all-time high early this year, topping US$1,000 per ounce for the first time, before retreating to US$850 per ounce to start May. The current price, just under US$900 per ounce, is significantly above the level last fall, at the time of our initiation note. Silver and copper prices are also higher than noted in our initiation note. These increases are only partially offset by lower current prices for lead and zinc.

  • Potentially higher capital costs
    The mining industry continues to experience cost pressures in excess of general rates of inflation, due to high demand for critical components, the rising price of oil, steel and other key commodities. Although most of these increases were factored into our earlier valuation, our revised model increases the capital cost by C$2m to account for inflationary pressures above our estimate. This exerts a slight negative influence on our valuation.

  • Our core valuation increases to C$0.27
    These factors are the driving force behind a modest net increase in our basecase valuation to C$0.27 per share, from the earlier C$0.25 per share noted in our December 2007 initiation note. Soho’s continued drilling offers further upside potential.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer